[1] 王文莉,李若瑜,王端礼,等.念珠菌对唑类药物耐药机理的探讨.中华皮肤科杂志,1997,30:306-309. [2] White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998, 11:382-402. [3] 牛云彤,李少平.白念珠菌毒力因子研究进展.中国微生态学杂志,2000,12:60-61. [4] White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41:1488-1494. [5] Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS:documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18:240-242. [6] White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 Suppl 1:S102-109. [7] Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun, 1986, 53:565-572. [8] Liu H. Transcriptional control of dimorphism in Candida albicans.Curr Opin Microbiol, 2001, 4:728-735. [9]Schaude M, Ackerbauer H, Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen, 1987,30:281-287. [9] Schaude M,Ackerbauer H,lnhibitory effect of antifungal agents on germ tube formation in Candida albicans.Mykosen, 1987,30:281-287. |